Pioneer and Leader in Next Generation Antibody Drug Conjugates Using Engineered Precision Biologics.

Expanded Genetic Code Technology Platform

We incorporate synthetic amino acids into proteins within living cells. The result? Product candidates designed for highly stable, site-specific conjugation, overcoming the inherent limitations of conventional conjugation approaches.

Focused Oncology Portfolio

We are advancing enhanced antibody drug conjugates and other engineered therapies to modulate the immune system as potential treatments for various cancer indications.